Overview

Indicated for the closure of skin wounds, including laparoscopic incisions and trauma-induced lacerations. May be used in conjunction with deep dermal stitches.

See How It Works

Watch Video

Order Information

Order Information
Code Description Shipper Case Quantity
CM001 INDERMIL® flexifuze™* Tissue Adhesive 1 Box

Clinical Evidence

  • Flexible([FOOTNOTE=Purdue Pascoe VOC report, report # J906 (slide 27) b. Report # CMPD-RR-16-009. Study to compare INDERMIL® FlexiFuze™ Topical Tissue Adhesive to competitor tissue adhesives for various properties, as reported by visual examination of product application on samples subject to repeated cyclic mechanical constraints.],[ANCHOR=],[LINK=]) - Has been designed to be a flexible adhesive when cured to maintain that flexibility over time1
  • Microbial Barrier([FOOTNOTE=Testing of Connexicon Adhesive Mixture as an effective barrier against microbial penetration. 2015],[ANCHOR=],[LINK=]) - In vitro studies have shown that it will stay in place for 5-8 days acting as an effective physical barrier to microbial penetration as long as the adhesive film remains intact([FOOTNOTE=Bench test results may not necessarily be indicative of clinical performance. Clinical studies were not conducted to demonstrate microbial barrier properties and a correlation between microbial barrier properties and a reduction in infection has not been established. Test organisms selected = Staphylococcus aureus,Staphylococcus epidermis, Candida albicans, Escherichia coli, Psuedomonas aeruginosa, MRSA, Vancomycin Resistant Enterococcus],[ANCHOR=],[LINK=])
  • Dye free formulation - No Discoloration of Wound Sites([FOOTNOTE=Scar Tattooing following the Use of Tissue Adhesive Swan, Marc C. M.R.C.S.; Descamps, Marjanne J. L. M.R.C.S.; Broadhurst, Andrew F.R.C.S.Nurse Pract 2001;13:10-12],[ANCHOR=],[LINK=])
  • Allows Patient to Shower Daily([FOOTNOTE=Testing of Connexicon Adhesive Mixture as an effective barrier against microbial penetration. 2015 *Bench test results may not necessarily be indicative of clinical performance. Clinical studies were not conducted to demonstrate microbial barrier properties and a correlation between microbial barrier properties and a reduction in infection has not been established. Test organisms selected = Staphylococcus aureus, Staphylococcus epidermis, Candida albicans, Escherichia coli, Psuedomonas aeruginosa, MRSA, Vancomycin Resistant Enterococcus],[ANCHOR=],[LINK=]) - After 1 hour and up to 5 to 8 days
  • High Wound Closure Strength([FOOTNOTE=Wound Closure Strength testing was carried out in accordance with ASTM F2458-05. Bench test results may not necessarily be indicative of clinical performance],[ANCHOR=],[LINK=])

  • * Property of Connexicon Medical Ltd.

  • † Report # CMPD-RR-16-009. Study to compare INDERMIL® FlexiFuze™ Topical Tissue Adhesive to competitor tissue adhesives for various properties *Bench test results may not necessarily be indicative of clinical performance